Skip to main content

Peer Review reports

From: Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials

Original Submission
24 Jul 2023 Submitted Original manuscript
11 Sep 2023 Reviewed Reviewer Report - Shebli Atrash
22 Sep 2023 Reviewed Reviewer Report
2 Oct 2023 Author responded Author comments - Joseph Kauer
Resubmission - Version 2
2 Oct 2023 Submitted Manuscript version 2
10 Oct 2023 Editorially accepted
21 Nov 2023 Article published 10.1186/s12885-023-11507-9

You can find further information about peer review here.

Back to article page